Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polygel Dual versus other antacids for heartburn and dyspepsia
PACTR202311905202771Phase 4Recruiting
- Sponsor
- Shalina Healthcare
- Start
- Nov 2023
- Countries
- 1
01
Overview
Phase 4 trial in gastroesophageal reflux disease (GERD) and dyspepsia (4 arms), sponsored by Shalina Healthcare. Primary endpoint: Change from baseline in Reflux Disease Questionnaire scores at day 14. Started Nov 2023; status: recruiting.
02
Conditions
gastroesophageal reflux disease (GERD)dyspepsia
Beyond the preview
Go deeper on PACTR202311905202771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311905202771.